These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 27716111

  • 1. Case report: Aqueous and Vitreous amino-acid concentrations in a patient with maple syrup urine disease operated on rhegmatogenous retinal detachment.
    Kanakis MG, Michelakakis H, Petrou P, Koutsandrea C, Georgalas I.
    BMC Ophthalmol; 2016 Oct 03; 16(1):170. PubMed ID: 27716111
    [Abstract] [Full Text] [Related]

  • 2. Amino-acid levels in subretinal and vitreous fluid of patients with retinal detachment.
    Bertram KM, Bula DV, Pulido JS, Shippy SA, Gautam S, Lu MJ, Hatfield RM, Kim JH, Quirk MT, Arroyo JG.
    Eye (Lond); 2008 Apr 03; 22(4):582-9. PubMed ID: 17948040
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quantification of Branched-Chain Amino Acids in Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Piri-Moghadam H, Miller A, Pronger D, Vicente F, Charrow J, Haymond S, Lin DC.
    Methods Mol Biol; 2022 Apr 03; 2546():65-81. PubMed ID: 36127579
    [Abstract] [Full Text] [Related]

  • 9. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
    Mescka CP, Wayhs CA, Guerreiro G, Manfredini V, Dutra-Filho CS, Vargas CR.
    Gene; 2014 Sep 15; 548(2):294-8. PubMed ID: 25046137
    [Abstract] [Full Text] [Related]

  • 10. Living related versus deceased donor liver transplantation for maple syrup urine disease.
    Feier F, Schwartz IV, Benkert AR, Seda Neto J, Miura I, Chapchap P, da Fonseca EA, Vieira S, Zanotelli ML, Pinto e Vairo F, Camelo JS, Margutti AV, Mazariegos GV, Puffenberger EG, Strauss KA.
    Mol Genet Metab; 2016 Mar 15; 117(3):336-43. PubMed ID: 26786177
    [Abstract] [Full Text] [Related]

  • 11. Successful pregnancy in maple syrup urine disease: a case report and review of the literature.
    Grünert SC, Rosenbaum-Fabian S, Schumann A, Schwab KO, Mingirulli N, Spiekerkoetter U.
    Nutr J; 2018 May 12; 17(1):51. PubMed ID: 29753318
    [Abstract] [Full Text] [Related]

  • 12. The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease.
    Kindt E, Halvorsen S.
    Am J Clin Nutr; 1980 Feb 12; 33(2):279-86. PubMed ID: 6101930
    [Abstract] [Full Text] [Related]

  • 13. Glutamate and gamma-aminobutyric acid neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinemia encephalopathies in newborn calves.
    Dodd PR, Williams SH, Gundlach AL, Harper PA, Healy PJ, Dennis JA, Johnston GA.
    J Neurochem; 1992 Aug 12; 59(2):582-90. PubMed ID: 1352800
    [Abstract] [Full Text] [Related]

  • 14. Reduction of large neutral amino acid concentrations in plasma and CSF of patients with maple syrup urine disease during crises.
    Wajner M, Coelho DM, Barschak AG, Araújo PR, Pires RF, Lulhier FL, Vargas CR.
    J Inherit Metab Dis; 2000 Jul 12; 23(5):505-12. PubMed ID: 10947205
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Glucose and alanine metabolism in children with maple syrup urine disease.
    Haymond MW, Ben-Galim E, Strobel KE.
    J Clin Invest; 1978 Aug 12; 62(2):398-405. PubMed ID: 670400
    [Abstract] [Full Text] [Related]

  • 17. Treatment of maple syrup urine disease: Benefits, risks, and challenges of liver transplantation.
    Deon M, Guerreiro G, Girardi J, Ribas G, Vargas CR.
    Int J Dev Neurosci; 2023 Oct 12; 83(6):489-504. PubMed ID: 37340513
    [Abstract] [Full Text] [Related]

  • 18. Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease.
    Bridi R, Araldi J, Sgarbi MB, Testa CG, Durigon K, Wajner M, Dutra-Filho CS.
    Int J Dev Neurosci; 2003 Oct 12; 21(6):327-32. PubMed ID: 12927581
    [Abstract] [Full Text] [Related]

  • 19. Maple syrup urine disease: clinical, EEG, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity.
    Korein J, Sansaricq C, Kalmijn M, Honig J, Lange B.
    Int J Neurosci; 1994 Nov 12; 79(1-2):21-45. PubMed ID: 7744549
    [Abstract] [Full Text] [Related]

  • 20. Management of a Woman With Maple Syrup Urine Disease During Pregnancy, Delivery, and Lactation.
    Wessel AE, Mogensen KM, Rohr F, Erick M, Neilan EG, Chopra S, Levy HL, Gray KJ, Wilkins-Haug L, Berry GT.
    JPEN J Parenter Enteral Nutr; 2015 Sep 12; 39(7):875-9. PubMed ID: 24618664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.